2023 Inhibition in the CNS Gordon Research Conference and Gordon Research Seminar

2023年中枢神经系统戈登研究会议和戈登研究研讨会的抑制

基本信息

批准号：
10683610
负责人：
GORDON J FISHELL
金额：
$ 1万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-06-05 至 2024-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10683610
关键词：
Anesthetics Animal Model Atmosphere Attention Basic Science Brain Brain Diseases Central Nervous System Collaborations Color Country Disease Drug usage Electronics Environment Equilibrium Fostering Functional disorder GABA Receptor Gender Generations Genetic Goals Growth Health Hour Human International Knowledge Lesbian Gay Bisexual Transgender Queer Link Mental disorders Mentors Methods Molecular Nervous System Neurodevelopmental Disorder Neurons Neurotransmitters Operative Surgical Procedures Positioning Attribute Postdoctoral Fellow Preparation Research Resolution Role Schizophrenia Science Scientist Series Signal Transduction Switzerland Synapses Therapeutic Thinking Training Translational Research Translations Woman Work autism spectrum disorder career design disability fundamental research gamma-Aminobutyric Acid gender equality graduate student in vivo insight meetings nervous system disorder neural circuit neuropsychiatric disorder neurotransmission new therapeutic target novel novel therapeutic intervention programs receptor symposium

项目摘要

Project Summary The next Gordon Research Conference (GRC) on inhibition in the Central Nervous System will be convened at Les Diablerets, Switzerland, on July 16-21, 2023. This international research conference has been held every two years since 2005 as part of the GRC conference series. As in previous years, it will be preceded on July 15-16, 2023, by the Gordon Research Seminar (GRS), which provides a unique atmosphere for junior scientists, including postdocs and graduate students, to discuss and exchange novel findings and ideas in preparation for the GRC. Inhibition in the Central Nervous System is mainly driven by the neurotransmitter GABA, which has been proven to be fundamental for brain function and, when the perturbed result in dysfunction. The GRC will provide a major forum where leaders in the field and junior scientists who are rising new stars will have the opportunity to exchange novel concepts and approaches to advance the field. The general scientific goal of this meeting is to explore leading topics in the field of inhibition in healthy brains and to better understand the role of altered inhibition in neurological and neuropsychiatric disorders. To achieve this goal, the meeting will pursue the following specific aims: to select speakers that will discuss cutting-edge fundamental research questions in inhibition within health and disease, to increase diversity and promote network collaborations, and provide training, networking and career promotion of graduate students and postdocs. The meeting will attain these aims by selecting 34 world-class speakers and 9 discussion leaders, many of whom are junior group leaders from 13 different countries (20 US-based scientists, 17 women). There is growing evidence linking GABA deficits to neurodevelopmental and neurological disorders. As such, the GRC/GRS meetings' emphasis on health impact will maximize discussion of fundamental questions in this field and seek novel therapeutic targets of inhibitory circuitries to treat devastating brain disorders.

项目摘要下届戈登研究会议（GRC）关于中枢神经系统的抑制作用将在瑞士LES Diablerets，2023年7月16日至21日。该国际研究会议已举行自2005年以来，作为GRC会议系列的一部分两年。与往年一样，它将在7月之前戈登研究研讨会（GRS）15-16，2023，为初级提供独特的氛围包括博士后和研究生在内的科学家讨论和交换新颖的发现和想法为GRC准备。中枢神经系统的抑制作用主要由神经递质驱动 GABA，已被证明是大脑功能至关重要的，当扰动导致脑部功能时功能障碍。 GRC将提供一个主要的论坛新明星将有机会交换新颖的概念和方法以推进该领域。这这次会议的一般科学目标是探索健康大脑抑制领域的主要主题更好地理解抑制作用改变在神经和神经精神疾病中的作用。实现这一目标，会议将追求以下具体目标：选择将讨论前沿的演讲者基本研究问题在健康和疾病中抑制，增加多样性并促进网络合作，并提供研究生的培训，网络和职业促进和博士后。会议将通过选择34位世界一流的演讲者和9个讨论来实现这些目标领导人，其中许多是来自13个不同国家的初级团体领导者（20位美国科学家，17个女性）。越来越多的证据将GABA缺陷与神经发育和神经系统疾病联系起来。因此，GRC/GRS会议强调健康影响将最大程度地讨论基本该领域的问题并寻求抑制性电路的新型治疗靶点来治疗毁灭性的大脑疾病。